Stock analysts at Mizuho started coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research note issued to investors on Wednesday, The Fly reports. The brokerage set a “neutral” rating on the biopharmaceutical company’s stock. Several other research firms have also commented on VSTM. HC Wainwright reiterated a “buy” rating and issued a […]